Ayala Pharmaceuticals (NASDAQ:ADXS) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research report released on Wednesday morning. The brokerage issued a sell rating on the stock. Separately, LADENBURG THALM/SH SH restated a neutral rating on shares of Ayala Pharmaceuticals in a research report on Thursday, November 16th. Check Out Our Latest Report […]

Leave a Reply

Your email address will not be published.

Previous post Atlantic American (NASDAQ:AAME) Earns Hold Rating from Analysts at StockNews.com
Next post Affimed (NASDAQ:AFMD) Receives New Coverage from Analysts at StockNews.com